What Semdor Pharma Group does

Semdor Pharma Group GmbH is a privately held German pharmaceutical group headquartered in Cologne that operates as Europe's only full-service pharmaceutical company for narcotics with its own medical cannabis brand. The group consolidates five wholly-owned subsidiaries — Cannamedical Pharma GmbH (medical cannabis import from Canada, Australia, and the Netherlands), PS Pharma GmbH (specialist logistics, serialization, primary packaging, and cold-chain distribution for narcotics and pharmaceuticals), PB Pharma (BfArM-authorized import and marketing of EU pharmaceuticals in Germany, including the Painbreak and Cyclocaps product lines and 500+ preparations), Cannalivery (a direct-to-patient online pharmacy for medical cannabis), and Bloombase (a digital infrastructure platform unifying telemedicine, prescription workflows, and pharmacy inventory management) — under a single corporate umbrella. Founded by David Henn in 2016 through Cannamedical and expanded into a group structure by 2021, the business serves European wholesalers, suppliers, pharmacies, and clinical facilities with narcotics and medical cannabis products.

The group monetizes through transaction-based pharmaceutical import and wholesale distribution, specialist logistics and serialization services for narcotics, BfArM-authorized parallel imports priced below domestic originals, and direct-to-patient online pharmacy sales of medical cannabis. Proprietary technical assets include a radio wave treatment process for microbiological reduction on cannabis flowers (an alternative to gamma irradiation) and the Bloombase digital platform, which the group positions as an integrated alternative to fragmented prescription and inventory tools. Operations are carried out under GDP and GMP certifications, with cold-chain pharmaceutical distribution and EU-GMP white-label cannabis products forming part of the 2022 service expansion. Group-wide revenue, funding history, and detailed ownership are not publicly disclosed; David Henn serves as authorized representative (Geschäftsführer).

Name

Semdor Pharma Group

Legal name

Semdor Pharma Group GmbH

Website

https://semdor-group.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Short description

Semdor Pharma Group is a privately held German pharmaceutical group operating Cannamedical, PS Pharma, PB Pharma, Cannalivery, and Bloombase to import, manufacture, distribute, and digitally orchestrate narcotics and medical cannabis products for European wholesalers, pharmacies, clinical facilities, and patients.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceuticals

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Pharmacies and Drug Retailers (456110)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

akta.pro secondary industries

Controlled Substances & Compliance-Focused Pharmaceutical Distributors (HLAIAJAN), Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC), Specialty Pharmacy & Biologics Distribution (CRAOAHAD), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

• Pharmaceutical distribution
• Medical cannabis products
• Narcotics logistics
• Pharmaceutical manufacturing
• Online pharmacy services

Headquarters

HQ city

Cologne

HQ country

Germany

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Cannabis Import and Distribution: Cannamedical Pharma imports high-quality medical cannabis products from Canada, Australia, and the Netherlands, distributing to pharmacies and clinical facilities. This is the core revenue driver for the group.
2. Narcotics and Pharmaceutical Logistics: PS Pharma Group provides specialist logistics services including storage, import/export, order picking, shipping, repackaging, and serialization of narcotics and pharmaceuticals under the Narcotics Act.
3. EU Pharmaceutical Imports: PB Pharma imports and markets original pharmaceutical products from EU countries for the German market, authorized through BfArM. Offers products at lower prices than domestic originals.
4. Online Pharmacy - Cannalivery: Direct-to-patient online pharmacy specializing in medicinal cannabis delivery, providing patients with easy and fast access to medical cannabis products.
5. White-Label Cannabis Products: PS Pharma Group offers exclusive EU-GMP certified white-label cannabis products on the European market.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Core offering

Semdor Pharma Group is a German-based full-service pharmaceutical company specializing in narcotics and medical cannabis. Through its subsidiaries (Cannamedical Pharma, PS Pharma, PB Pharma, Cannalivery, and Bloombase), the group imports, manufactures, packages, distributes, and markets narcotics, medical cannabis, and other pharmaceuticals to European wholesalers, pharmacies, clinical facilities, and directly to patients.

Product overview

Semdor Pharma Group is Europe's only full-service pharmaceutical company for narcotics with its own medical cannabis brand. The group comprises five main subsidiaries: Cannamedical Pharma (medical cannabis import from Canada, Australia, Netherlands), Cannalivery (online medical cannabis pharmacy), PS Pharma (specialist narcotics logistics, serialization, packaging, cold-chain distribution), PB Pharma (narcotics marketing with Painbreak and Cyclocaps product lines), and Bloombase (digital platform unifying telemedicine, prescription workflows, and pharmacy inventory management). The group offers the broadest range of narcotics and medical cannabis to European wholesalers, suppliers, and pharmacies.

Differentiator

Problem solved

Functional benefit

Brands

• Cannamedical: Medical cannabis brand importing products from Canada, Australia, and Netherlands
• Cannalivery
• PS Pharma
• PB Pharma
• bloombase

Products and services

• Cannamedical Pharma Import and distribution of high-quality medical cannabis products from Canada, Australia, and the Netherlands to pharmacies and clinical facilities across Europe.
• Cannalivery Specialized online pharmacy delivering medicinal cannabis directly to patients, providing simple and fast access to high-quality medical cannabis products.
• PS Pharma Logistics Services Specialist logistics provider for narcotics and pharmaceuticals offering storage, import/export, order picking, shipping, serialization, primary packaging of cannabis flowers, filling of cannabis extracts and oils, and cold-chain pharmaceutical distribution.
• PB Pharma Pharmaceutical Products Pharmaceutical marketing company specializing in narcotics with over 20 years of experience marketing imported EU pharmaceutical products (including own Painbreak and Cyclocaps lines) for the German market under BfArM authorization.
• Bloombase Digital Platform Digital backbone infrastructure platform for the medical cannabis market that unifies telemedicine, prescription workflows, and pharmacy inventory management in one integrated system from medical consultation through prescription routing to batch and inventory management.
• Painbreak PB Pharma's own pharmaceutical product line for narcotics marketed in the German market.
• Cyclocaps PB Pharma's own pharmaceutical product line for narcotics marketed in the German market.

Quantifiable outcome

• Highest possible product standards ensured through quality management system
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Neuraxpharm: European specialty pharmaceutical company (HQ Germany) focused on CNS and specialty products, with narcotics/specialty pharmacy distribution capabilities. Compares to PB Pharma in EU-imported pharmaceutical marketing and BfArM-authorized distribution.
• Demecan: German medical cannabis producer and distributor with BfArM authorization, importing and distributing cannabis flower to German pharmacies. Direct competitor to Cannamedical with similar pharmaceutical-grade positioning, but without Semdor's parallel narcotics logistics and EU pharma import arms.
• Cansativa: German medical cannabis importer/distributor serving pharmacies with similar BfArM-authorized cannabis imports. Competes with Cannamedical on product range, supplier relationships (Canadian/Australian), and pharmacy service levels in the same end market.
• Medios AG: German specialty pharmaceutical distributor focused on compounded and specialty medications (including narcotics) serving pharmacies. Operates in similar downstream pharmacy channel as Semdor's PB Pharma/PS Pharma, with comparable regulatory intensity.
• Pohl-Boskamp: German specialty pharmaceutical company with established narcotics/BtM expertise and marketed products in pain and respiratory. Highly comparable to PS Pharma and PB Pharma in BtM positioning and German pharmacy channel relationships.

Broad incumbents

• STADA Arzneimittel: Large German specialty/generics pharma group with growing medical cannabis activities and broad European wholesale distribution. Broader portfolio than Semdor, but a competitor on EU-imported generics (vs PB Pharma) and on cannabis (vs Cannamedical).
• Canopy Growth Corporation (Canopy Medical): Global cannabis company with European medical cannabis operations (Spectrum Therapeutics) supplying pharmacies. Competes with Cannamedical on imported flower and brand positioning, but at much broader global scale.
• Tilray Brands: Global cannabis operator with German distribution via Tilray Medical and a sizable European pharmaceutical/cannabis footprint. Competes with Semdor on the import and wholesale side, but is a broad incumbent rather than a narcotics/specialist niche player.

Others

• Aenova Group: European pharmaceutical CDMO/manufacturer offering serialization, packaging, and cold-chain capabilities that partially overlap with PS Pharma's narcotics logistics and packaging services. More of an enabling/adjacent player than direct competitor in the medical cannabis vertical.

Emerging players

• Dr. Reddy's Laboratories (European business): Global generics manufacturer with EU product imports and selective specialty pharmacy positioning relevant to PB Pharma's EU-import-authorized model. Less directly competitive in narcotics and cannabis, but exercises similar import-margin arbitrage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Semdor Pharma Group